Mehmet Ay

8PUBLICATIONS
16CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMolecular targetsBiologically active moleculesChemical engineering designGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 02, 2025
New and potential boron-containing compounds for treatment of Alzheimer's disease and cancers.

Ferah Comert Onder, Kadircan Ural, Alper Onder

|Nov 07, 2024
Synthesis, in silico and bio-evaluation studies of new isothiocyanate derivatives with respect to COX inhibition and H2S release profiles.

Yakup Berkay Yilmaz, Tuğba Güngör, Serhat Dönmez

|Sep 25, 2024
Novel benzothiazole/benzothiazole thiazolidine-2,4-dione derivatives as potential FOXM1 inhibitors: In silico, synthesis, and in vitro studies.

Khaled A N Abusharkh, Ferah Comert Onder, Venhar Çınar

|Jan 04, 2024
Synthesis of new imine-/amine-bearing imidazo[1,2-a]pyrimidine derivatives and screening of their cytotoxic activity.

Tuğba Güngör, Hazal Nazlıcan Atalay, Yakup Berkay Yilmaz

|Jun 21, 2021
Correction to "Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth In Vivo".

Ferah Comert Onder, Nermin Kahraman, Esen Bellur Atici

|Mar 06, 2020
Delivery of Small Molecule EF2 Kinase Inhibitor for Breast and Pancreatic Cancer Cells Using Hyaluronic Acid Based Nanogels.

Ferah Comert Onder, Selin Sagbas Suner, Nurettin Sahiner

Pageof 2

Frequent Collaborators

2 joint publications

Serdar Durdağı

2 joint publications

Tuğba Güngör

2 joint publications

Hazal Nazlıcan Atalay

2 joint publications

Yakup Berkay Yilmaz